JPRN-UMIN000007836已完成2 期
Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinoma - Phase II study of Zometa+RT for bone metastasis from RCC
Shizuoka Cancer Center Japanese Radiation Oncology Study Group0 个研究点目标入组 30 人开始时间: 2012年4月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Surgery is needed for bone metastasis 2)Hypercalcemia 3)Dental problem
研究者
相似试验
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
进行中（未招募）
1 期
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsEUCTR2016-003468-38-FRCentre François baclesse
已完成
不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder10004994Bladder carcinomabladder cancerNL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
招募中
2 期
Phase II study of chemoradiotherapy combined with gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancernresectable locally advanced pancreatic cancerJPRN-UMIN000028116agoya University Pancreatic Tumor Bord25
招募中
1 期
Phase I study for simultaneous radiochemotherapy of relapsed ovarian cancerC51-C58Malignant neoplasms of female genital organsDRKS00008552niversitätsklinikum für Strahlentherapie6